Dr Domenick J Sorresso, MD | |
7614 Jacque Rd Ste C, Hudson, FL 34667-7195 | |
(727) 857-5967 | |
(727) 857-5972 |
Full Name | Dr Domenick J Sorresso |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 35 Years |
Location | 7614 Jacque Rd Ste C, Hudson, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013917160 | NPI | - | NPPES |
46527 | Other | BLUE CROSS BLUE SHIELD | |
257232000 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | ME77399 (Florida) | Secondary |
207RP1001X | Internal Medicine - Pulmonary Disease | MR77399 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Regional Medical Center Bayonet Point | Hudson, FL | Hospital |
Entity Name | Clinicare Clinical Services, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609818145 PECOS PAC ID: 3870505092 Enrollment ID: O20100325000817 |
News Archive
While newly published research confirms that under laboratory circumstances prion-protein can be absorbed across the gut, it also shows that this is unlikely to occur in real life.
In a study of patients with muscle-invasive bladder cancer who had undergone radical cystectomy, cigarette smoking was linked with poor response to cisplatin-based chemotherapy.
Identifying the sun-protection practices and risk profiles of beachgoers may help determine those who would benefit from targeted interventions intended to reduce the risk of skin cancer, according to a study in the November issue of Archives of Dermatology.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and nine-month periods ending September 30, 2011.
Researchers at Ghent University, Belgium, have found a promising treatment for the most frequent form of blindness in the elderly.
› Verified 1 days ago
Entity Name | C & D Pulmonary, P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932469566 PECOS PAC ID: 4486801024 Enrollment ID: O20120904000425 |
News Archive
While newly published research confirms that under laboratory circumstances prion-protein can be absorbed across the gut, it also shows that this is unlikely to occur in real life.
In a study of patients with muscle-invasive bladder cancer who had undergone radical cystectomy, cigarette smoking was linked with poor response to cisplatin-based chemotherapy.
Identifying the sun-protection practices and risk profiles of beachgoers may help determine those who would benefit from targeted interventions intended to reduce the risk of skin cancer, according to a study in the November issue of Archives of Dermatology.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and nine-month periods ending September 30, 2011.
Researchers at Ghent University, Belgium, have found a promising treatment for the most frequent form of blindness in the elderly.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Domenick J Sorresso, MD 7614 Jacque Rd Ste C, Hudson, FL 34667-7195 Ph: (727) 857-5967 | Dr Domenick J Sorresso, MD 7614 Jacque Rd Ste C, Hudson, FL 34667-7195 Ph: (727) 857-5967 |
News Archive
While newly published research confirms that under laboratory circumstances prion-protein can be absorbed across the gut, it also shows that this is unlikely to occur in real life.
In a study of patients with muscle-invasive bladder cancer who had undergone radical cystectomy, cigarette smoking was linked with poor response to cisplatin-based chemotherapy.
Identifying the sun-protection practices and risk profiles of beachgoers may help determine those who would benefit from targeted interventions intended to reduce the risk of skin cancer, according to a study in the November issue of Archives of Dermatology.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and nine-month periods ending September 30, 2011.
Researchers at Ghent University, Belgium, have found a promising treatment for the most frequent form of blindness in the elderly.
› Verified 1 days ago
Dr. Deborah Saepharn, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2966 | |
Ramya Pinnamaneni, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 14100 Fivay Rd Ste 380, Hudson, FL 34667 Phone: 727-868-9208 Fax: 727-868-6420 | |
Dr. Anthony Maurice Salibi, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2966 Fax: 727-819-2928 | |
Dr. Nicholas Cohen Kolinsky, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2966 Fax: 727-819-2928 | |
Benjamin Kuritzky, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7651 Medical Dr, Hudson, FL 34667 Phone: 727-868-9208 Fax: 727-868-6420 | |
Dr. Luis R. Annoni-suau, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 14100 Fivay Rd, Suite 310, Hudson, FL 34667 Phone: 727-862-3202 Fax: 727-862-2182 |